Funding · Company
OnKure, Inc.
Boulder, COBiotech & Pharma
OnKure, Inc. of Boulder, CO has disclosed $110M across 2 Form D offerings filed with the SEC between Mar 4, 2022 and Apr 3, 2023.
$110M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$54M
Form D · Apr 3, 2023 ↗
Q2 2023
· target $60M
Filing details
HeadquartersBoulder, COIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001533914Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →